Enhancing FDA’s Patient-Focused Drug Development: Leveraging Clinakos’ Integrated Patient Data™ and Medically Smart AI™ for a Competitive Advantage
As the pharmaceutical industry transitions to a patient-centric model, real-world data is increasingly used to inform drug development and regulatory decisions. Including the perspectives of patients, caregivers, and advocates in drug development improves the design of clinical trials, selection of endpoints, and regulatory review processes. This strategy aims to concentrate research on treatments that address […]
